Silicon &
science.

London, UKGolden TriangleAI + pharma

DEEPC sits at the intersection of computational chemistry and pharmaceutical science . We built it to reverse Eroom's Law: PhD-level formulation science backed by purpose-built AI, cutting formulation timelines from months to minutes.

Rooted in
rigor.

For decades, pharmaceutical development has been constrained by Eroom's Law, where formulation development becomes slower and more expensive over time. We were founded to reverse this curve.

Research RootsBuilt on decades of peer-reviewed research from Imperial College London, Cambridge, and Oxford. Our models are validated against chemical law. Every agent is built by pharmaceutical scientists who’ve taken molecules through regulatory approval.
Engineering ScaleOur engineering team built the Reality Anchor, the constraint layer that stops AI from hallucinating chemistry. While generic models fabricate facts, DeepCeutix agents are bound by thermodynamics and regulatory reality.
Strategic LocationBased in the UK’s Golden Triangle, the densest corridor of pharmaceutical and AI talent in Europe. We use that proximity to tie academic rigor to enterprise-grade engineering.
London, United Kingdom

Operating from the Golden Triangle, the densest corridor of pharmaceutical research and AI talent in Europe.

The
architects.

Pharmaceutical scientists, AI engineers, and enterprise operators.

Dr. Moe Elbadawi
EXEC.01

Dr. Moe Elbadawi

CEO & Co-Founder

Stanford Top 2% Scientist in pharmaceutical science (2022-present). PhD Mechanical Engineering, MSc Biomedical Engineering, BSc Pharmacology. 3,000+ citations across AI-driven formulation design and 3D pharmaceutical printing. One of few researchers to take ML models from theory to physical drug manufacturing.

Stanford Top 2%  /  PhD MechEng  /  3000+ Citations
LinkedIn →
Yusuf Mohammed
EXEC.02

Yusuf Mohammed

Head of AI & Co-Founder

MSc Artificial Intelligence for the Biosciences. Applied ML and AI to formulation design at an innovator pharma company before building the neural networks behind DeepCeutix, including the Reality Anchor, the constraint system that stops generative models from hallucinating chemistry.

AI Biosciences  /  Neural Architect  /  Pharma ML
LinkedIn →
Jawad Ashraf
EXEC.03

Jawad Ashraf

Chairman of the Board

Serial entrepreneur, 30+ years building and scaling technology companies. Multiple exits. Jawad runs the operational side of DeepCeutix, making sure the science actually ships as enterprise software.

Serial Entrepreneur  /  30+ Years Exp  /  Strategic Scale
LinkedIn →

Validated
network.

Backed by world-class technology partners and validated through strategic collaborations with industry-leading organizations.

01
M2M Pharma logo
M2M PharmaKing's Award 2024
Strategic Partner

A King's Award winner providing physical material science oversight and wet-lab validation. M2M's empirical testing ensures DeepCeutix agents stay grounded in laboratory reality, not abstract models.

02
NVIDIA Inception logo
NVIDIA InceptionInception Program
Technology Partner

Member of NVIDIA's Inception Program. Access to GPU computing and AI infrastructure for training pharmaceutical formulation models.

03
EIT Health logo
EIT HealthEU Innovation Network
Network Partner

Part of the European Institute of Innovation & Technology's health network, connecting DeepCeutix with Europe's leading health innovators and research institutions.

Book a demo.

Tell us what you are working on (molecule, indication, stage, open question).

A formulation lead will be in touch within a business day.

By submitting, you agree to our Privacy Policy.